Angiotensin II Receptor Blockade Physiological and Clinical Implications [electronic resource]

  • Dhalla, Naranjan S. editor. , Zahradka, Peter. editor. , Dixon, Ian M. C. editor. , Beamish, Robert E. editor.
  • 1998
Angiotensin II Receptor Blockade Physiological and Clinical Implications [electronic resource]
  • Data Type
  • Title/Author
    Angiotensin II Receptor Blockade Physiological and Clinical Implications[electronic resource] / edited by Naranjan S. Dhalla, Peter Zahradka, Ian M. C. Dixon, Robert E. Beamish.
  • Author
    Dhalla, Naranjan S., editor., Zahradka, Peter., editor., Dixon, Ian M. C., editor., Beamish, Robert E., editor.
  • Authors
    SpringerLink (Online service)
  • Phy Desc.
    XLIII, 588 p. : online resource.
  • Total State.
    Progress in Experimental Cardiology,1389-1774 ; 2
  • Contents Note
    A. Pharmacological Interruption of Renin-Angiotensin in Hypertension -- 1. Pharmacological Interruption of the Renin System and the Kidney: Lessons from Comparative Pharmacology -- 2. The Brain Renin-Angiotensin System and Salt-Sensitive Hypertension -- 3. At1 Angiotensin Receptor Blockade and Angiotensin-Converting Enzyme Inhibition: Effects on Vascular Remodeling and Endothelial Dysfunction in SHR -- 4. Cellular Physiology of Angiotensin II Receptors in Vascular Smooth Muscle Cells -- 5. Angiotensin II Enhanced the Expression of Inhibitory Guanine Nucleotide Regulatory Protein in Vascular Smooth Muscle Cells: Blockade by AT1 Antagonist -- 6. Comparison of the Inhibitory Actions of Angiotensin AT1 Receptor Antagonists in the Peripheral Vascular Bed -- 7. Angiotensin II Receptor Antagonists in Patients with Renal Failure and on Hemodialysis -- 8. The Place of Angiotensin II Antagonists in Relation to the Canadian Hypertension Society Guidelines -- 9. Translating Clinical Guidelines for Management of Heart Failure and Hypertension into Clinical Practice -- 10. Cough Induced by Pharmacological Modulation of the Renin-Angiotensin-Aldosterone System. Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Antagonists -- B. Angiotensin Blockade and Cardiovascular Disease -- 11. Angiotensin II Receptors AT1 and AT2: New Mechanisms of Signaling and Antagonistic Effects of AT1 and AT2 -- 12. Angiotensin Receptor Antagonists and Cardiovascular Remodeling -- 13. Intersubject Variability in the Pharmacokinetics of Losartan -- 14. Functional Analysis of Tissue Renin-Angiotensin System Using ?쏥ain and Loss of Function??Approaches: In vivo Test of in vitro Hypothesis -- 15. Exploring the Difference Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Antagonists. A Focus on Bradykinin -- 16. Role of Cytokines in Septic Cardiomyopathy -- 17. In Pursuit of Optimal Care and Outcomes for Patients with Congestive Heart Failure: Insights from the Past Decade -- 18. Atherosclerosis: Implications of Angiotensin II and the AT-1 Receptor -- 19. Influence of AT1 Receptor Inhibition on Cardiac Function and Structure of Diabetic Rats -- 20. Role of Myocardial Tissue Angiotensin (Ang.) II in Cardiac Pathology -- C. Angiotensin Blockade and Cardiac Hypertrophy and Heart Failure -- 21. Mechanical Stress, Local Renin-Angiotensin System and Cardiac Hypertrophy. An Overview -- 22. Role of Renin-Angiotensin System in Cardiac Hypertrophy and Failure -- 23. Effect of Angiotensin-Converting Enzyme Inhibition and of Angiotensin II Receptor Blockade on the Development of Cardiac Hypertrophy in Rats -- 24. Effects of Inhibition of Angiotensin-Converting Enzyme on Myocardial and Myocyte Remodeling in Chronic Volume Overload-Induced Cardiac Hypertrophy in the Dog -- 25. The Site of Angiotensin Generation: Focus on the Heart -- 26. Angiotensin II-Mediated STAT Signal Transduction: Studies in Neonatal Rat Cardiac Fibroblasts and CHO-K1 Cells Expressing At1A Receptors -- 27. Cardiac Angiotensin II Subtype 2 Receptor Signal Transduction Pathways: Embryonic Cardiomyocytes and Human Heart -- 28. Angiotensin II Stimulates Contractility and C-fos Gene Expression in Isolated Atrial Human Myocardium -- 29. Stimulation of the Na+/Ca2+ Exchanger by Angiotensin II -- 30. Developmental Regulation of the Cardiac Renin-Angiotensin System: Expression and Association with Growth and Apoptosis -- 31. Angiotensin II-Regulated Apoptosis in Cardiovascular Remodeling -- 32. The Role of Angiotensin II in Stretch-Activated Signal Transduction of the Normal, Hypertrophied, and Failing Adult Heart -- D. Angiotensin Blockade And Remodeling Of Heart In Myocardial Infarction -- 33. Role of Angiotensin II Receptor Blockade During Remodeling After Myocardial Infarction -- 34. Local Angiotensin II and Tissue Repair Post-Myocardial Infarction -- 35. Losartan Pretreatment Inhibits an Early Activation of Matrix Metalloproteinases in Acute Myocardial Infarction -- 36. The Role of Angiotensin II in Post-Translational Regulation of Fibrillar Collagens in Fibrosed and Failing Rat Heart -- 37. Characteristics and Mechanisms of Angiotensin II-Related Myocardial Damage -- 38. Comparison of Direct Angiotensin II Receptor Blockade with Converting Enzyme Inhibition in the Rat Model of Heart Failure -- 39. Effects of Captopril on Myocardial Oxidative Stress Changes in Post-MI Rats -- 40. Role of Angiotensin in Angiogenesis and Cardiac Fibrosis in Heart Failure -- 41. Role of Angiotensin II in Myocardial Ischemia/Reperfusion Injury -- 42. Effects of Angiotensin II Receptor Antagonist on Cardiac Remodeling in Cardiomyopathic Hamster Hearts.
  • Topical Term
    Medicine & Public Health.
  • Host Item
    Springer eBooks
  • Additional Item
    Printed edition: 9781461376316
  • ISBN
  • Language